Fair and Equal Treatment To All FDA Clients, Consumers and Other Stakeholders

The Office of the Director General and the Center Directors have received reports from recently hired Food and Drug Administration (FDA) regular and contractual employees that there were incidents of some company liaison officers and regulatory affairs officers, who have been dropping names of FDA employees, who already resigned or retired from government service, in an effort to get special treatment or accommodation.  

Download attachments to continue reading.


Download this file (FMC2013-029.pdf)FMC2013-029.pdf

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter